Headlines

Novo Nordisk partners with OpenAI in weight loss drug race

Novo Nordisk, the maker of popular weight-loss drugs Ozempic and Wegovy, is partnering with OpenAI to deploy the technology across its operations as it looks to keep pace with rapid expansion in the obesity drug market. The Danish company announced in a statement on Tuesday

IMF cuts 2026 global growth forecast on Mideast war

The IMF cut its 2026 global growth projection Tuesday, warning that the world economy could be "thrown off course" by war in the Middle East -- as the conflict roils commodity markets and sparks higher prices. The global economy is set to grow by 3.1 percent this year, said the